Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder Disorders
    1.
    发明申请
    Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder Disorders 审中-公开
    鞘磷脂脂质体治疗膀胱过多活动障碍

    公开(公告)号:US20120128762A1

    公开(公告)日:2012-05-24

    申请号:US13350326

    申请日:2012-01-13

    摘要: The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to prevent, manage, ameliorate and/or treat disorders involving neuropathic pain and aberrant muscle contractions, such as what occurs in bladder hyperactivity disorders such as interstitial cystitis (IC) in animals or humans in need thereof. Also provided is a liposome-based delivery of drugs, e.g., antibiotics, pain treatments and anticancer agents, to the bladder, genitourinary tract, gastrointestinal system, pulmonary system and other organs or body systems. In particular, liposome-based delivery of vanilloid compounds, such as resiniferatoxin, capsaicin, or tinyatoxin and toxins, such as botulinum toxin is provided for the treatment of bladder conditions, including pain, inflammation, incontinence and voiding dysfunction.

    摘要翻译: 本发明提供用于滴注含有鞘磷脂或鞘磷脂代谢物的脂质体的脂质载体的药物组合物和方法,以预防,治疗,改善和/或治疗涉及神经性疼痛和异常肌肉收缩的疾病,例如膀胱多动障碍 作为有需要的动物或人类的间质性膀胱炎(IC)。 还提供了对膀胱,泌尿生殖道,胃肠系统,肺系统和其他器官或身体系统的基于脂质体的药物递送,例如抗生素,疼痛治疗和抗癌剂。 特别地,提供了基于脂质体的递送香草素化合物,例如树脂毒素,辣椒素或微量毒素和毒素,例如肉毒杆菌毒素,用于治疗膀胱状况,包括疼痛,炎症,失禁和排尿功能障碍。

    Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
    2.
    发明授权
    Sphingomyelin liposomes for the treatment of hyperactive bladder disorders 有权
    鞘磷脂脂质体用于治疗膀胱过动症

    公开(公告)号:US08110217B2

    公开(公告)日:2012-02-07

    申请号:US11546025

    申请日:2006-10-11

    IPC分类号: A61K9/127

    摘要: The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to prevent, manage, ameliorate and/or treat disorders involving neuropathic pain and aberrant muscle contractions, such as what occurs in bladder hyperactivity disorders such as interstitial cystitis (IC) in animals or humans in need thereof. Also provided is a liposome-based delivery of drugs, e.g., antibiotics, pain treatments and anticancer agents, to the bladder, genitourinary tract, gastrointestinal system, pulmonary system and other organs or body systems. In particular, liposome-based delivery of vanilloid compounds, such as resiniferatoxin, capsaicin, or tinyatoxin and toxins, such as botulinum toxin is provided for the treatment of bladder conditions, including pain, inflammation, incontinence and voiding dysfunction.

    摘要翻译: 本发明提供用于滴注含有鞘磷脂或鞘磷脂代谢物的脂质体的脂质载体的药物组合物和方法,以预防,治疗,改善和/或治疗涉及神经性疼痛和异常肌肉收缩的疾病,例如膀胱多动障碍 作为有需要的动物或人类的间质性膀胱炎(IC)。 还提供了对膀胱,泌尿生殖道,胃肠系统,肺系统和其他器官或身体系统的基于脂质体的药物递送,例如抗生素,疼痛治疗和抗癌剂。 特别地,提供了基于脂质体的递送香草素化合物,例如树脂毒素,辣椒素或微量毒素和毒素,例如肉毒杆菌毒素,用于治疗膀胱状况,包括疼痛,炎症,失禁和排尿功能障碍。

    Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
    3.
    发明申请
    Sphingomyelin liposomes for the treatment of hyperactive bladder disorders 有权
    鞘磷脂脂质体用于治疗膀胱过动症

    公开(公告)号:US20070122466A1

    公开(公告)日:2007-05-31

    申请号:US11546025

    申请日:2006-10-11

    IPC分类号: A61K9/127

    摘要: The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to prevent, manage, ameliorate and/or treat disorders involving neuropathic pain and aberrant muscle contractions, such as what occurs in bladder hyperactivity disorders such as interstitial cystitis (IC) in animals or humans in need thereof. Also provided is a liposome-based delivery of drugs, e.g., antibiotics, pain treatments and anticancer agents, to the bladder, genitourinary tract, gastrointestinal system, pulmonary system and other organs or body systems. In particular, liposome-based delivery of vanilloid compounds, such as resiniferatoxin, capsaicin, or tinyatoxin and toxins, such as botulinum toxin is provided for the treatment of bladder conditions, including pain, inflammation, incontinence and voiding dysftunction.

    摘要翻译: 本发明提供用于滴注含有鞘磷脂或鞘磷脂代谢物的脂质体的脂质载体的药物组合物和方法,以预防,治疗,改善和/或治疗涉及神经性疼痛和异常肌肉收缩的疾病,例如膀胱多动障碍 作为有需要的动物或人类的间质性膀胱炎(IC)。 还提供了对膀胱,泌尿生殖道,胃肠系统,肺系统和其他器官或身体系统的基于脂质体的药物递送,例如抗生素,疼痛治疗和抗癌剂。 特别地,为了治疗膀胱状况,包括疼痛,炎症,失禁和排尿功能障碍,提供了香草素化合物(例如树脂毒素,辣椒素或微量毒素)和毒素(例如肉毒杆菌毒素)的基于脂质体的递送。